CHEREESE ROWE: Open Payments
NPI 1699020057 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 11 payments from 5 companies in 2025. Trend: 2023 $234 · 2024 $410 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $180 |
| UCB, Inc. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| LEO Pharma Inc. | 1 | $29 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: RINVOQ, Bimzelx, GEMTESA, ANZUPGO, SLYND, SKYRIZI.
Industry payments across GA — which companies pay providers there.
